Soleno Therapeutics
The Rare Disease Specialist at Soleno Therapeutics is responsible for leading the commercial launch and sales efforts of a treatment for Prader-Willi syndrome, engaging with healthcare professionals and caregivers to build long-term relationships, raise awareness, and support patient care with empathy.
Soleno Therapeutics, a Neurocrine Biosciences company, is focused on the development and commercialization of novel therapeutics for the treatment of rare genetic disorders. Inspired by patients and families around the world, the company works to advance promising research that can make a meaningful difference for individuals living with complex, life-threatening rare diseases with unmet medical needs. Soleno is headquartered in Redwood City, California.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Soleno Therapeutics.
63% above the average for this role